在Tet2驱动的克隆性血液形成中,大动脉动脉瘤通过巨细胞与骨质细胞类似的分化驱动大动脉瘤
Jun Yonekawa1, Yoshimitsu Yura1, Junmiao Luo1
1Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
The Journal of clinical investigation
|February 25, 2026
概括
克隆性造血,一种与年龄相关的干细胞突变,加速了大动脉动脉瘤的生长. 这通过Tet2缺乏的巨细胞促进骨质细胞样变化和MMP9发生,这表明大动脉疾病的新治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 大动脉动脉瘤是危险的与年龄相关的扩张,具有高破裂风险.
- 免疫细胞是动脉瘤发展的关键驱动因素.
- 克隆性血液形成 (CH),在衰老中很常见,会改变免疫功能,但其在动脉瘤中的作用尚不清楚.
研究的目的:
- 调查CH对大动脉动脉瘤病变的贡献.
- 确定CH影响动脉瘤进展的机制.
主要方法:
- 针对患者样本进行超深度测序,以检测CH突变.
- 鼠标模型:将Tet2缺乏的骨髓移植到ApoE敲击的小鼠中,然后输注血管新生素II以诱导动脉瘤.
- 对巨细胞表型和MMP9表达的分析.
- 抑制骨质细胞分化 (遗传和药理学).
主要成果:
- 与CH相关的突变在患者中普遍存在,并且与动脉瘤扩张速度更快相关.
- 与对照组相比,缺乏Tet2的CH小鼠显示大动脉扩张显著增加.
- 缺乏Tet2的巨体表现出类似骨质细胞的表型,并增加了MMP9的产生.
- 抑制骨质细胞分化减少了Tet2介导的动脉瘤生长.
结论:
- Tet2驱动的CH加速了大动脉动脉瘤的进展.
- 这种加速是由产生MMP9的骨质细胞类巨细胞介导的.
- Tet2驱动的CH代表了大动脉动脉瘤的潜在治疗标.
相关概念视频
Hematopoiesis
9.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K
Lineage Commitment
4.5K
Commitment is the process whereby stem cells:
4.5K
Osteoclasts in Bone Remodeling
4.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
Production of Formed Elements
5.0K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
5.0K
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Differentiation of Common Myeloid Progenitor Cells
4.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.1K


